We are live on ! Find out more
DRIOW

DarioHealth Corp. Warrant

Delisted

DRIOW was delisted on the 4th of March, 2021.

3 hedge funds and large institutions have $2K invested in DarioHealth Corp. Warrant in 2019 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 3 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 33 (0)

60% less capital invested

Capital invested by funds: $5K → $2K (-$3K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
3
Holders Change
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
3
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$1K -$135 -6,006 -15%
BA
2
Bard Associates
Illinois
$1K -$43 -1,900 -3%
UBS Group
3
UBS Group
Switzerland
-$59 -2,607 -38%

DRIOW Hedge Fund Activity: Q4 2019 in Review

3 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in DarioHealth Corp. Warrant (DRIOW) for Q4 2019, worth a combined $2K — down 60% from $5K a quarter earlier.

Fund positioning in DRIOW was balanced in Q4 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 3 trimmed.

The largest seller was Susquehanna International Group, cutting an estimated $135.

  • 3 institutional investors held DarioHealth Corp. Warrant (DRIOW) as of Q4 2019, unchanged from Q3 2019.
  • Funds reported $2K of DarioHealth Corp. Warrant stock for Q4 2019, down 60% quarter-over-quarter.
  • 0 funds opened new DarioHealth Corp. Warrant positions in Q4 2019 and 0 closed out.
  • The largest DarioHealth Corp. Warrant seller in Q4 2019 was Susquehanna International Group, an estimated $135 sold.

Based on aggregated 13F filings for Q4 2019.